Long-term follow-up of voluntary ingestion of Helicobacter pylori.
Morris
A J
AJ
Duke University Medical Center, Durham, North Carolina.
Ali
M R
MR
Nicholson
G I
GI
Perez-Perez
G I
GI
Blaser
M J
MJ
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D001729:Bismuth; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005756:Gastritis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D016481:Helicobacter Infections / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D016480:Helicobacter pylori / Q000302:isolation & purification; D006801:Humans; D008297:Male; D009942:Organometallic Compounds / Q000627:therapeutic use; D012008:Recurrence; D012459:Salicylates / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D009942:Organometallic Compounds; D012459:Salicylates; C015715:bismuth subsalicylate; D001729:Bismuth